Skip to main content
Top
Published in: Lung 6/2014

01-12-2014

Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension

Authors: Monica Lapa, Milena M. P. Acencio, Alberto Q. Farias, Lisete R. Teixeira, Caio J. C. Fernandes, Carlos P. Jardim, Mario Terra-Filho

Published in: Lung | Issue 6/2014

Login to get access

Abstract

Purpose

The aim of this study was to evaluate the expression profiles of the relevant selectins and PDGF in schistosomiasis-associated pulmonary hypertension.

Methodology

Patients with three distinct clinical profiles were enrolled in the study: IPAH(n = 11), schistosomiasis-associated PH (Sch-PH))(n = 13), and schistosomiasis without PH (Sch) (n = 13). Healthy volunteers, were recruited as a control group(n = 13). Echocardiography was performed in all groups, and the PH patients underwent right heart catheterization. Plasma soluble adhesion molecules E- and P-Selectin, PDGF-AB, PDGF-BB were determined by ELISA.

Results

E-selectin was significantly increased in the IPAH group compared with the other groups [the control, Sch + PH and Sch groups) (p < 0.001) (Fig. 2)]. P-selectin was lower in Sch (20.2 + 8.9 × 103 pg/mL) as compared to the control, (43 16.8 × 103 pg/mL), IPAH (35.8 7.8 × 103 pg/mL), and Sch + PH (36.8 ± 15.7 × 103 pg/mL) (p = 0.005) groups. Serum PDGF-BB levels were higher in the control group (8.9 ± 4.8 × 103 pg/mL) compared with the IPAH (3.7 ± 2.17 × 103 pg/mL), Sch + PH (5.2 ± 3.7 × 103 pg/mL) and Sch (2.4 ± 1.7 × 103 pg/mL) groups (p < 0.05). PDGF-AB levels were also higher in the control group (25.6 ± 8.6 × 103 pg/mL), compared with the other three groups, being the Sch group the one with lower serum levels of this marker (11.4 ± 8.6 × 103 pg/mL) (p = 0.006).

Conclusions

In conclusion, vascular inflammation in schistosomiasis, with or without PH, is different from IPAH suggesting distinct pathophysiological mechanisms associated with the development of pulmonary hypertension.
Literature
1.
2.
go back to reference Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266CrossRef Badesch DB, Champion HC, Sanchez MAG, Hoeper MM, Loyd JE et al (2009) Diagnosis and assessment of pulmonary hypertension. J Am Coll Cardiol 54(1):255–266CrossRef
4.
go back to reference Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.1055/s-0029-1233314 CrossRefPubMed Souza R, Fernandes CJ, Jardim CV (2009) Other causes of PAH (schistosomiasis, porto-pulmonary hypertension and hemolysis-associated pulmonary hypertension). Semin Respir Crit Care Med 30(4):448–457. doi:10.​1055/​s-0029-1233314 CrossRefPubMed
5.
go back to reference Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523CrossRefPubMed Lapa MS, Dias B, Jardim C, Fernandes CJC, Dourado P, Figueiredo M, Farias A, Tutsui J, Terra-Filho M, Humbert M, Souza R (2009) Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 119:1518–1523CrossRefPubMed
6.
go back to reference Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766CrossRefPubMed Butrous G, Ghofrani HA, Grimminger F (2008) Pulmonary vascular disease in the developing world. Circulation 118:1758–1766CrossRefPubMed
7.
go back to reference Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009CrossRefPubMed Conceição MJ, Borges-Pereira J, Coura JR (2007) A thirty years follow-up study on Schistosomiasis mansoni in a community of Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 102(8):1007–1009CrossRefPubMed
8.
go back to reference Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109CrossRefPubMed Lambertucci JR, Serufo JC, Gerspacher-Lara R, Rayes AAM et al (2000) Schistosoma mansoni: assessment of morbidity before and after control. Acta Trop 77:101–109CrossRefPubMed
9.
go back to reference Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720CrossRef Fernandes CJCS, Jardim CVP, Hovnanian A, Hoette S, Dias BA, Souza S, Humbert M, Souza R (2010) Survival in schistosomiasis-associated pulmonary arterial hypertension. J Am Coll Cardiol 56:715–720CrossRef
10.
go back to reference Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)CrossRefPubMed Cahill PARE, Sitzmann JV (2001) Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 89:273–293 (2001)CrossRefPubMed
11.
go back to reference Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131CrossRefPubMed Richter J (2000) Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Trop 77:111–131CrossRefPubMed
12.
go back to reference Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238 Cichoz-Lach HCK, Stomka M, Kasztelan-Szczerbinska B (2008) Pathophysiology of portal hypertension. J Physiol Pharmacol 59(Suppl 2):231–238
13.
go back to reference Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230CrossRefPubMed Cella G, Belloto F, Tona F, Sbarai A, Mazzaro G, Motta G, Fareed J (2001) Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 120:1226–1230CrossRefPubMed
14.
go back to reference Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.1016/j.jacc.2009.04.018 CrossRef Morrel NW, Adnot S, Archer SL, Dupuis J, Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA, Weissmann N, Yuan JX-Y, Weir EK (2009) Cellular and molecular basis of pulmonary arterial hypertension. J Am Coll Cardiol 54(1):s20–s31. doi:10.​1016/​j.​jacc.​2009.​04.​018 CrossRef
15.
go back to reference Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29sCrossRefPubMed Graham BB, Bandeira AP, Morrell NW, Butrous G, Tuder RM (2010) Schistosomiasis-associated pulmonary hypertension: pulmonary vascular disease: the global perspective. Chest 137(6 Suppl):20s–29sCrossRefPubMed
16.
go back to reference Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.1007/s00018-012-0950-4 CrossRefPubMed Barrier M, Meloche J, Jacob MH, Courboulin A, Provencher S, Bonnet S (2012) Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension. Cell Mol Life Sci 69(17):2805–2831. doi:10.​1007/​s00018-012-0950-4 CrossRefPubMed
17.
go back to reference Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165CrossRefPubMed Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109:159–165CrossRefPubMed
18.
go back to reference Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.1164/rccm.200707-1037OC07-1037OC CrossRef Perros F, Montani D, Dorfmuller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Herve P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M (2007) Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178(1):81–88. doi:10.​1164/​rccm.​200707-1037OC07-1037OC CrossRef
19.
go back to reference Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701CrossRefPubMed Trottein F, Nutten S, Angeli V, Delerive P et al (1999) Schistosoma mansoni schistosomula reduce E-selectin and VCAM-1 expression in TNF-alpha-stimulated lung microvascular endothelial cells by interfering with NF-kappaB pathway. Eur J Immunol 29:3691–3701CrossRefPubMed
20.
go back to reference Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325CrossRefPubMed Soares S, Rodrigues-Junior V, Silva DTN, Moraes-Souza H (2007) Participation of platelets in the process of fibrosis in patients with mansonic schistosomiasis. schistosomiasis. Rev Soc Bras Med Trop 40(3):321–325CrossRefPubMed
21.
go back to reference Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419CrossRefPubMed Vezozzo DCP, Farias AQ, Cerri GG, da Silva LC, Carrilho FJ (2006) Assessment of portal hemodynamics by doppler ultrasound and of liver morphology in the hepatospleinc and hepatointestinal forms of Schistosomiasis mansoni. Dig Dis Sci 51:1413–1419CrossRefPubMed
22.
go back to reference Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28CrossRefPubMed Hatz C, Jenkins JM, Ali QM, Abdel-Wahab MF, Cerri GG, Tanner M (1992) A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. Acta Trop 51:15–28CrossRefPubMed
23.
go back to reference Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRefPubMed Pereira CA, Sato T, Rodrigues SC (2007) New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 33(4):397–406CrossRefPubMed
24.
go back to reference Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54CrossRef Simmonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliot CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R (2009) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54(1):S43–S54CrossRef
25.
26.
go back to reference Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing Rather LJ, Virchow RLK, Schwalbe J (1990) A commentary on the medical writings of Rudolf Virchow: based on Schwalbe’s Virchow-Bibliographie, 1843–1901. Norman Publishing
27.
go back to reference Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029CrossRefPubMed Witters P, Freson K, Verslype C, Peerkink K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D (2008) Review article: blood platelet count number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther 27:1017–1029CrossRefPubMed
28.
go back to reference Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499CrossRefPubMed Eddahibi E, Humbert M, Sediame S, Chouaid C et al (2000) Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension. Am J Respir Crit Care Med 162:1493–1499CrossRefPubMed
Metadata
Title
Selectins and Platelet-Derived Growth Factor (PDGF) in Schistosomiasis-Associated Pulmonary Hypertension
Authors
Monica Lapa
Milena M. P. Acencio
Alberto Q. Farias
Lisete R. Teixeira
Caio J. C. Fernandes
Carlos P. Jardim
Mario Terra-Filho
Publication date
01-12-2014
Publisher
Springer US
Published in
Lung / Issue 6/2014
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-014-9643-0

Other articles of this Issue 6/2014

Lung 6/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.